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Abstract
Following the personalized medicine paradigm, there is a growing interest in
medical agents capable of predicting the effect of therapies on patients, by
exploiting the amount of data that is now available for each patient. In dis-
ciplines like oncology, where images and scans are available, the exploitation
of medical images can provide an additional source of potentially useful in-
formation. The study and analysis of features extracted by medical images,
exploited for predictive purposes, is termed radiomics. A number of tools
are available for supporting some of the steps of the radiomics process, but
there is a lack of approaches which are able to deal with all the steps of the
process.
In this paper, we introduce a medical agent-based decision support sys-
tem capable of handling the whole radiomics process. The proposed system
is tested on two independent data sets of patients treated for rectal can-
cer. Experimental results indicate that the system is able to generate highly
performant centre-specific predictive model, and show the issues related to
differences in data sets collected by different centres, and how such issues can
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affect the performance of the generated predictive models.
Keywords: Decision Support Systems, Radiomics, Predictive Models,
Image Feature Analysis
1. Introduction1
Personalized medicine is a relatively new, but already well-established,2
paradigm based on the principle that each individual is born with unique3
biological and genetic characteristics [1, 2]. The foundation of this paradigm4
is formed by disciplines such as Genomics –the science of studying the genes5
in a genome and their interactions with each other–, and proteomics –which6
instead focuses on proteins. Furthermore, in disciplines like oncology, where7
images and scans are available, the exploitation of medical images can pro-8
vide an additional source of potentially useful information. Thanks also9
to the recent advances in computer science, it is now possible to extract a10
huge number of “quantitative“ features from tomographic images (computed11
tomography [CT], magnetic resonance [MR], or positron emission tomogra-12
phy [PET] images), and such extracted features can then be automatically13
analysed in order to investigate their informativeness with regards to the14
evolution of the disease, or the response of the patient to a specific clinical15
treatment. This discipline is commonly termed radiomics [3], and is aimed16
at providing effective decision support to physicians and practitioners, and17
complementing the traditional “qualitative” analysis of images, commonly18
performed by human experts [4]. In this context, features represent a nu-19
merical synthesis of some properties of the considered image, which would20
not be possible to manually extract and analyse. Extracted features can21
then be combined with available clinical data into complex models to predict22
patient prognosis or benefit from a specific therapy.23
Remarkably, evidence that radiomics can be helpful for predicting tu-24
mour control or clinical complications has been documented for most of the25
common modalities (CT, MRI, PET, etc.) and anatomical districts –such as26
lung, rectum, or brain– [5, 6, 7, 8].27
The growing interest in radiomics lead to the development of several28
specifically-designed tools; examples include cGITA [9], TexRAD [10, 11],29
moddicom [12], Pyradiomics [13], and CERR [14]. In parallel with the grows30
of radiomics tools, initiative such as the Image Biomarker Standardisation31
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Initiative [15] and the Radiomics Ontology1 become important to standardise32
the different aspects of image processing and features extraction.33
However, despite the growing number of radiomics tools, to the best of34
our knowledge there is a lack of agents that can deal with all the steps of the35
radiomics process, thus providing a complete and modular environment for36
supporting the generation and analysis of the predictive models, and allow-37
ing the exploitation of models in everyday medical routine. Existing tools38
are mainly aimed at facilitating the extraction of features, and at extend-39
ing the set of features that can be extracted from a medical image, only.40
Pivotal steps, like feature selection and generation of the actual predictive41
model –either via traditional statistical approaches or recent machine learn-42
ing techniques– are ignored. More worryingly, existing tools do not natively43
provide any support for the external validation of generated models. As a re-44
sult, a crucial issue of the exploitation of radiomics predictive models, is that45
their portability between centres or hospitals is unclear. This is also due to46
the fact that different machines, particularly in MRI, provide medical images47
with very different characteristics, particularly in terms of visual noise. Such48
differences can strongly affect the predictive capabilities of the generated49
models, and invalidate the results. A possible way for tackling this issue is50
to extensively exploit external independent testing sets, and providing tools51
that are supportive in this regards, in order to validate the generated models52
[16, 17, 18]. Similarly, features can be analysed in order to identify those53
which are more robust to common sources of image noise. However, despite54
the fact that empirical investigations which rely on external validation are55
deemed to be qualitative better than others by the TRIPOD guidelines [19],56
this approach can not guarantee the reproducibility of the observed results57
in every set [20].58
The contribution of this paper is twofold. First, we introduce an approach59
–under the form of a medical agent-based decision support system– for sup-60
porting the whole radiomics process. In its current implementation, the agent61
incorporates some of the ideas and functionalities of moddicom [12]. Given62
a set of medical images, the proposed system is able to extract a wide range63
of features, to analyse and select them with regards to the outcome to pre-64
dict, and to generate an optimised predictive model. When data from a new65
patient is provided as input, the proposed agent is able to collect features66
1https://bioportal.bioontology.org/ontologies/RO
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from available medical images and patient’s data, and to return a predic-67
tion about the clinical outcome of a proposed treatment. In other words,68
the agent can be provided high level goals to achieve –such as, generate a69
predictive model that shows some given properties–, and it able to reason70
upon available knowledge in order to satisfy, whether possible, the goals.71
This reduces the burden on human experts, and provides a valuable decision72
support tool, that can also allow to investigate alternative approaches and73
models. The agent is centre-specific, but has been designed in order to be74
capable of exchanging models between agents in different centres and testing75
generated models on different data, thus supporting external validation. As76
a second contribution, we investigate the capabilities of the proposed agent77
in a real-world scenario. We consider two sets of medical images acquired by78
two different centres for treating patients affected by rectal cancer. By train-79
ing the system on each set, we empirically demonstrate how the differences80
in data sets collected by different centres can affect the performance of the81
generated predictive models.82
The remainder of this paper is organised as follows. Section 2 describes83
the structure of the proposed system and gives details of the considered84
features. In Section 3 the data sets are introduced, and empirical results are85
then presented. An extensive discussion is provided in Section 4. Finally,86
conclusions are given.87
2. The Proposed Agent88
The architecture of the proposed agent-based decision support system is89
depicted in Figure 1, and the corresponding software is available at https:90
//github.com/robertogattabs/RadAgent. The exploitation of an agent-91
based approach has a number of advantages. An agent can cope with high92
level goals, such as generate models that maximise given metrics, by taking93
into account all the steps of the process. In facts, the agent can reason upon94
overall and step-specific knowledge in order to modify the behaviour of the95
corresponding modules, so that the overall goals are achieved. The modular96
architecture supports the agent by (i) allowing the development and exploita-97
tion of off-the-shelf modules that can be substituted without any modifica-98
tion to the rest of the architecture; (ii) providing a standardised interface99
between the modules; and (iii) allow to modify parameters and behaviour of100
each component, and isolating the effects on the overall performance.101
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Figure 1: The overall architecture of the proposed decision support system for radiomics, in
terms of modules and input/output. The modules included in the architecture correspond
to the steps to be performed in the radiomics process. Generated models can be internally
validated (green module) or exploited for predicting the outcome of a previously unseen
clinical case, and support the physicians.
The system has been designed in order to being able to deal with all the102
steps of a radiomics analysis, and to provide useful information and support103
to the physicians. It is worth emphasising that clinicians are generally not104
very keen to exploit predictive models that can not be inspected and validated105
“clinically”. For this reason, in the rest of this paper we focus on machine106
learning techniques, such as logic regression or decision trees, that allows to107
generate predictive models that can be analysed by human experts –but that108
yet can provide reasonably high performance.109
Main functionalities of the proposed system, that can be performed au-110
tomatically or required by the users, include:111
• Features extraction from both original medical images, and images fil-112
tered using the well-known Laplacian over Gaussian convolution kernel113
(LoG) [16]. The LoG filter is commonly exploited in order to smooth114
the high frequency noise and enhance the variation of values among115
adjacent pixels in the images.116
• The LoG filter can return images with very different appearance ac-117
cording the value of the σ parameter used. It is therefore important118
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to identify the σ values that lead to most significant and informative119
features being extracted for the considered outcome to be predicted.120
σ values are selected by a Mann-Whitney test with the clinical out-121
come (to identify the most representative σ) and exploiting a cross-122
correlation matrix, assessed via a p Pearson Test (to allow the use of123
two different σ for the same feature in case of no-correlation between124
the feature at the two σ values).125
• Signatures of selected features, i.e. subsets of informative features, are126
evaluated. Signatures are generated via greedy forward selection, and127
are assessed according to metrics provided by the user. In our analysis128
we considered the AUC with regards to a logistic regression.129
• Signatures are then exploited for generating predictive models, and130
are compared with regards to their predictive ability. The signature131
that leads to the best predictive model is selected in order to be used132
by the agent to support the decisions of the human expert, on new133
testing cases. Optionally, performance and characteristics of the best134
performing features can also be presented to the user, which can decide135
to exploit a different set of features than those included in the signature136
identified by the agent.137
Noteworthy, the introduced agent has a high level of configurability, that138
allows it to be optimised according to the characteristics of the images and139
data sources of the centre. In order to maximise its compatibility with ex-140
isting systems, it has been developed in R, which is one of the most used141
environments for statistical analysis in medicine. Results of the analysis can142
be exchanged between agents, in order to (externally) validate results or143
evolve the generated predictive models.144
The architecture is agnostic with regards to the element to be predicted145
and to the available features. For the purposes of this work, we consider 92146
types of features, that can be classified as follows:147
• BASIC: first order image features [15] extracted by considering as-148
pects such as Morphological (MRF), Statistical (STAT), and Intensity149
Histogram (HI) of the image. Features in this set also include shape150
properties, such as Volume, Surface, Surface to volume ratio, Com-151
pactness, Sphericity, Centre of mass shift, Mean, Variance, Skewness,152
Kurtosys, etc.;153
6
• GLCM: Grey level co-occurrence based textural features [15]. Features154
in this set include Mean, Variance, Skewness, Kurtosis, 10th and 90th155
percentile, Robust mean absolute deviation, Energy, etc.;156
• GLRLM: Grey level run length based textural features [15]. Examples157
of features in this set are Short and Long runs emphasis, Short and Long158
run low grey level emphasis, Grey level non-uniformity normalised, Run159
entropy, etc.160
• GLDZM: Grey level size zone based textural features [15]. Features161
include Grey level non-uniformity, Zone size non-uniformity, Zone per-162
centage, Zone size entropy, etc.163
It should be noted that the value of a feature also depends on the con-164
sidered σ used in the LoG filter. In this implementation of the system, for165
the sake of efficiency, we consider 9 possible σ values: 0.35, 0.49 , 0.54, 0.59,166
0.64, 0.69, 0.74, 0.79, 0.84. Such values has been selected according to the167
experimental results achieved in [21]. The use of 9 possible σ values leads168
to a grand total of 734 features (Morphological and shape features, from the169
Basic set, are not affected by changes in the LoG filter) considered by the170
approach for generating the predictive model. The complete list of features171
considered in this work is provided in appendix. For a detailed description172
of the features, including the actual mathematical formulas, the interested173
reader is referred to [15].174
3. Experimental Analysis175
The main purpose of this experimental analysis is to assess the useful-176
ness of the proposed radiomics agent in supporting the different steps of a177
radiomics investigation. It is therefore beyond the scope of this study to thor-178
oughly compare the performance of differently generated predictive models.179
For a clinical evaluation of mathematical predictive models, the interested180
reader is referred to [16].181
The experimental analysis considers two data sets of T2-weighted fast182
spin-echo 2D oblique images MR scans, that are used for treating patients183
affected by rectal cancer. The first data set includes scans of 173 patients184
from the Gemelli polyclinic hospital in Rome, the second set is composed by185
25 clinical cases treated at the Maastro clinic of the Maastricht university186
medical centre. Both the data sets of images include manual contouring187
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of the clinical target volume (CTV) [22]. CTV includes the gross tumour188
volume, which is the region already affected by the tumour, as well as the189
regions of direct, local subclinical spread of disease that must be treated in190
order to stop the evolution of the tumour.191
The different size of the sets provides an interesting test-bed for a ra-192
diomics decision support system. Typical medical sets can show a significant193
size variability, according to the typology of tumour considered and to the194
characteristics of the medical centre.195
The scanner used at the Gemelli polyclinic hospital is a MR 1.5 T unit196
(Signa Excite GE Medical Systems), while the Maastro clinic is equipped197
with a Siemens Magnetom AVANTO machine. Acquisition parameters were198
homogeneous for the two data sets, and are as follows:199
• repetition time, 2500–5000 msec;200
• inversion time, 100–110 msec;201
• pixel spacing, ca. 0.7 mm;202
• echo train length, 16–24;203
• section thickness, 3 mm;204
• no intersection gap;205
Images have been acquired in a transverse plane orthogonal to the tu-206
mour longitudinal axis. No intravenous contrast medium was administered.207
The subsequent manual contouring was performed by an expert radiation208
oncologist, using a radiotherapy delineation console (Eclipse, Varian Medical209
System) for the definition of lesion outline as defined in ICRU n. 83.2210
Figure 2 shows two MR slices from the Gemelli polyclinic data set (left),211
and two MR slices acquired at the Maastro clinic. Noteworthy, despite the212
strict observance of acquisition procedures and acquisition parameters, it is213
easy to notice that acquired images are significantly different. Qualitatively,214
images acquired at the Gemelli polyclinic include more visual noise, particu-215
larly at high frequencies, than those acquired by the other centre. Moreover,216
2https://icru.org/testing/reports/prescribing-recording-and-reporting-intensity-
modulated-photon-beam-therapy-imrt-icru-report-83
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Figure 2: Two MR slices from the Gemelli polyclinic set (left) and from the Maastro clinic
(right). Images show significant differences in terms of high frequency noise (upper left),
horizontal lines (bottom left), and spotted blurring artefact (upper and bottom right).
Such artefacts have been highlighted using red arrows, for the sake of readability.
some horizontal interferences can be spotted (and are pointed in the fig-217
ure). On the other hand, images acquired at the Maastro clinic may present218
blurring artefacts, as highlighted in the figure.219
In order to provide the appropriate input for the proposed approach, MR220
scans have been processed using the moddicom R library [12]. Moddicom is221
an open source library that allows to: (i) deal with DICOM files in order to222
extract images and contouring information; (ii) process and store extracted223
data; and (iii) analyse stored data to extract morphological and structural224
features. DICOM (Digital Imaging and Communications in Medicine) is225
a standard for storing and transmitting medical images enabling the inte-226
gration of medical imaging devices such as scanners, servers, workstations,227
printers, network hardware, and picture archiving and communication sys-228
tems (PACS) from multiple manufacturers.229
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The clinical outcome to be predicted trough the generation of radiomics-230
based models is the pathological complete response (pCR) after surgery,231
which indicates that there is no residual histological evidence of tumour after232
surgery. pCR is increasingly found to be a reasonable surrogate for long-term233
favourable outcomes [23]. In the considered datasets, 21–23% of the cases234
show a positive pCR. The output of the proposed approach comes in the235
form of probability of pCR; while the threshold can be provided as input by236
the user, in this case we exploited a 50%-value threshold. Remarkably, the237
probability value provides implicitly an estimation of the reliability of the238
prediction: the closer the probability is to 50%, the lower the confidence.239
With the aim of limiting the possibility of overfitting, predictive models240
are evaluated using a 10-fold cross-validation strategy.241
Performance are measured in terms of specificity and sensitivity. The242
former measures the so-called true negative rate, i.e., the proportion of nega-243
tive cases that are correctly identified as such. In our analysis, negative cases244
correspond to the presence of residual histological evidence of tumour, and245
the absence of a complete pathological response. Sensitivity (also called the246
true positive rate) focuses on the proportion of correctly classified positive247
cases.248
3.1. Results249
Hereinafter we will refer to the predictive model trained, using the pro-250
posed framework, on the data set from the Gemelli polyclinic and the Maastro251
clinic, as respectively, Ag.G and Ag.M. On the basis of the considered train-252
ing data, the optimisation procedure included in the architecture lead to the253
generation of differently-structured predictive models:254
• The Ag.G model is based on a logistic regression built using cT (clinical255
T stage), the zone size entropy [15] after the application of a LoG256
with σ = 0.35 and the Skewness of the grey-level distribution after the257
application of a LoG with σ = 0.59.258
• The Ag.M predictive model is based on two covariates, the Grey level259
co-occurrence correlation [15] obtained with a σ = 0.84 and the Grey260
level co-occurrence joint entropy obtained with a σ = 0.54. The agent261
decides automatically the number of covariates to consider according262
to the size of the provided training set.263
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Figure 3: ROC curve of the predictive model trained on the Gemelli polyclinic’s data set
(left) and on the data acquired by the Maastricht clinic (right). Blue is used to indicate the
ROC observed on the training set, –in cross-validation. Red indicates the ROC obtained
on the (external) testing set.
It should be noted that the automated optimisation is performed greedily,264
following the expected AUC value.265
Figure 3 shows the receiver operating characteristic curve (ROC) of Ag.G266
and Ag.M on both the training set (blue) and the external testing set (red).267
Unsurprisingly, the performance of the models tend to be better on the train-268
ing set, rather than on the testing set. This is because the testing set images269
are affected by a different type of noise than the training set ones (examples270
have been discussed in Figure 2). The extremely good performance of Ag.M271
on the same data from the Maastricht clinic is possibly due to two main272
reasons: (i) the limited size of the set, which may result in some overfitting;273
and (ii) the fact that images acquired by the Maastricht clinic show a very274
limited noise, or a type of noise to which considered features are robust.275
3.1.1. Features Analysis276
To shed some light on the informativeness and the significance of con-277
sidered features in the two data sets, we performed an univariate analysis278
between each feature and the pCR outcome to be predicted. The analysis279
was performed using the Mann-Whitney test (p < 0.05). Table 1 presents280
the results of the investigation in terms of number of features that have a281
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Table 1: Number of features that, at least at one σ value and according to an univariate
analysis performed using the Mann-Whitney test (p < 0.05), are correlated with the
outcome to predict. Features are grouped according to the class they belong to. Results
are provided for each considered data set, and also in terms of features which are relevant
for both sets.
BASIC GLCM GLRLM GLSZM
Policlinico Gemelli 8 9 5 4
Maastro clinic 4 9 2 3
Common features 1 4 1 1
correlation with the outcome to predict. For each feature, only the most282
representative σ has been considered. Features are grouped according to the283
class they belong to. As a first remark, we observe that out of the total set of284
available features, a large subset (more than 20%) has a significant correla-285
tion with the pCR outcome to be predicted. Considering that the univariate286
analysis can not take into account combinations of features, this result seems287
to suggest that considered features can be very informative, as they carry288
useful information for predicting the required pCR outcome.289
Results presented in Table 1 also highlight the limited overlap between290
the features deemed to be significant between the two data sets. In total, 7291
features are identified by the univariate analysis, for at least one σ value, in292
both the sets.293
• Entropy, BASIC;294
• Sum Entropy: Textural features, GLCM;295
• Correlation: Textural features, GLCM;296
• Sum variance: Textural features, GLCM;297
• Cluster tendency: Textural features, GLCM;298
• Run Entropy: Textural features, GLRLM;299
• Large zone high grey level emphasis: Textural features, GLDZM.300
Interestingly, most of the features (4) come from the GLCM class, which301
includes textural features about the grey level co-occurrence. This suggests302
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Figure 4: Cross-correlation matrices, using the Pearson correlation coefficient, obtained
by analysing the data set of the Gemelli polyclinic (left) and Maastro clinic (right) are
presented in the top half. Bottom half shows the distribution of the coefficients under the
form of histograms. 0.0 indicates that no correlation is found, while +1 (−1) identifies
cases with strong direct (inverse) correlation.
that this class is, in general, more robust with regards to the kind of noise303
that affects the medical images acquired by the two considered centres.304
Figure 4 shows the cross-correlation matrices of the extracted features,305
and the bivariate correlation –measured using the Pearson correlation coef-306
ficient. For the sake of readability, features in the histograms are ordered307
following the order used in the matrices. Evidence seems to indicate that in308
the Ag.G set, features have a lower correlation: the region around 0 is very309
populated. This is possibly due to the noisy of the images in the set, that310
may reduce the informativeness of extracted information. On the contrary,311
features in the Ag.M model show a higher level of correlation, as correlation312
values are evenly distributed among the scale.313
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Figure 5: The ROC of a predictive model created by considering as training data images
acquired by the Gemelli polyclinic. The model, called Ag.G*, shows to be more general
and robust than the Ag.G and Ag.M models, but it delivers slightly worse performance.
Blue is used to indicate the ROC observed on the training set, in cross-validation. Red
indicates the ROC obtained on the Maastro testing set.
3.1.2. General Predictive Models314
It is worth reminding that the Ag.M and Ag.G models have been op-315
timised by the proposed system in order to maximise the performance on316
images from the corresponding medical centre. Results presented in Figure317
3 indicate that trained model perform poorly on a different data set. There-318
fore, the question naturally arises: Is it possible to generate a more general319
and robust predictive model? To answer this question, we configured the320
proposed system in order to generate a predictive model according to the321
approach proposed in [21]: their work was based on a very limited set of322
features, and showed to be portable and robust. We refer to the resulting323
model as Ag.G*, because it has been trained using data from the Gemelli324
clinic. The Ag.G* model is based on a logistic regression built using cT (clin-325
ical T stage), the entropy of the grey-level distribution after the application326
of a LoG with σ=0.35 and the Skewness of the grey-level distribution after327
the application of a LoG with σ=0.49.328
Figure 5 shows the performance of the Ag.G* predictive model. Blue329
is used to indicate the ROC observed on the Gemelli training set, in cross-330
validation. Red indicates the ROC obtained on the Maastro testing set.331
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The generated predictive model provides an interesting trade-off between332
portability and performance: while the performance on the training set are333
not as good as those delivered by the Ag.G or Ag.M models, the Ag.G*334
approach is more robust when used on data from a different centre. This335
seems to indicate that it is possible to generate a more general and robust336
model, but at the cost of reduced performance on the specific set.337
4. Discussion338
According to the presented results, the proposed approach is able to deal339
with all the steps of a radiomics analysis on data gathered by different cen-340
tres. Specifically, the proposed framework showed to be capable of identifying341
a suitable set of informative feature to maximise the performance –measured342
in terms of AUC with regards to the outcome to be predicted– of a given343
class of predictive models. In this work, we focused on logistic regression, but344
the modularity of the framework allows to easily substitute logistic regression345
with a different class of approaches, or even to consider more approaches at346
once. We also highlighted how the framework can be exploited for comparing347
predictive models generated for different data sets, and how the correspond-348
ing features (and their characteristics) can be compared and analysed. Re-349
markably, this analysis can potentially lead to identify issues in the machines350
or in the environment, or even suggests the presence of procedural issues.351
The empirical results presented in the previous section seem to confirm352
the importance of centre-specific radiomics-based predictive models. Figure353
3 suggests that the use of “general” predictive models can lead to very poor354
predictive performance. However, results also clearly indicate the value of a355
radiomics-based decision support system, that can provide useful information356
to physicians and can lead to a more effective planning of the treatments for357
patients. A trade-off between portability and performance is presented in358
Figure 5: remarkably, the generated predictive model is less sensitive to the359
difference in the data sets, for instance in terms of image noise. On the360
other hand, general performance is worse than those that can be achieved by361
exploiting centre-specific models.362
Taking a different perspective, which is necessarily more speculative than363
the analysis of the results presented in the previous section, we can identify a364
number of ways in which the presented system can be exploited with regards365
to radiomics:366
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• For the sake of the explainability of the predictive models, a number367
of different models can be generated for predicting the same clinical368
outcome. In particular, emphasis can be given to approaches that369
generate models easy to investigate and analyse by humans, so that370
an expert user can visualise the generated model, and can explore the371
relevance of features with regards to the considered clinical outcome.372
While the number of features can be extremely large, focusing on the373
described classes of features can highlight the importance of a set of374
feature, that can be used all together.375
• The proposed framework can also allow users to provide as input a spe-376
cific set of features to be analysed. Such features are then exploited for377
generating predictive models, and can be compared in terms of relation378
and correlation. This may allow to investigate features believed to be379
informative in the relevant literature, and also to assess their usefulness380
in the presence of images acquired by using different machines, settings,381
or centres.382
• Different data sets can also be compared, in terms of relevant features.383
For instance, in the presence of large multi-centric studies, it may be384
useful to identify centres which acquire images with similar properties;385
that would reduce the noise of the analysis, and maximise the proba-386
bility of generating an highly performant yet general –with regards to387
the considered clinics– predictive model.388
The physicians involved in the experimental analysis positively evaluated389
the experience with the proposed agent. The agent allows the medical experts390
to focus on the actual goals of their investigation and analysis: optimisation391
and low-level details are optimised by the agent architecture without the392
need of human guidance. The agent, given a range of alternative modules to393
choose from, and the parametrisation of each module, can transparently test394
different alternatives in order to achieve the specified goal. In the presented395
experimental analysis, the goal was to generate a LR-based predictive model396
of the pCR of patients treated for rectal cancer. A very important aspect397
that the agent-based structure can support, but has not been integrated in398
the proposed system yet, is the ability to explain results, and to motivate399
the decisions. We are extremely interested in develop these aspects as part400
of our future work.401
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An important aspect to consider, particularly in the case of agent-based402
decision support system, is the ability to generalise on different data sets.403
This has been partly covered in the experimental analysis by considering404
images from two different centres. However, also due to the very limited405
amount of contoured images available in the radiomics field, it is hard to406
empirically demonstrate that the proposed agent will easily generalise on data407
sets where different type of cancer are treated. On this matter, a preliminary408
study performed by exploiting the proposed agent on a data set considering 15409
patients affected by glioblastoma (a form of brain cancer) seems to indicate410
that the agent, also due to its modularity, can generalise on significantly411
different sets of MRI images [24].412
The agent introduced in this work can play a central role in a distributed413
learning scenario [25], where different agents cooperate to converge to a ro-414
bust and shared predictive model while preserving the privacy of patients.415
This can be achieved by exploiting an iterative approach, shown in Figure 6,416
composed by four main steps: (a) Each centre trains a local model, (b) the417
models are sent to a Master, (c) the Master calculates a model, considering418
weighting the contribute of each centre with the cardinality of the locally419
available sets, then calculates some new coefficients for each node, (d) the420
coefficients are sent to each node and the process can be repeated until in a421
(c) step a convergence criteria is reached.422
However, we also envisage the use of the introduced agent in distributed423
learning scenarios where federated learning approaches are exploited [26],424
where there is no need for a master to coordinate learning and merge a425
general model.426
5. Conclusion427
Radiomics is a topic that is gaining a significant interest in the scientific428
community, as testified by the growing number of publications that can now429
be found on the online library of medicine-related articles Pubmed. While430
still in its infancy, a number of tools are now available for supporting ra-431
diomics, as well as standardisation initiatives. These initiatives, such as432
IBSI [15] are mainly aimed at maximising the reproducibility of results.433
Despite the growing interest and the number of already available tools,434
there is a lack of agents that can deal with all the steps of the radiomics435
process. Existing tools are mainly aimed at facilitating the extraction of436
features, and at extending the set of features that can be extracted from a437
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Figure 6: An example of a possible architecture of cooperative agents to converge to a
robust and shared model by an iterative approach. Initially, each centre trains a local
model using its local agent (a), that is then sent to a Master (b). The master agent
merges the models into a general one (c), and send it back to each centre (d).
medical image, only. Crucial aspects, such as features selection, correlation438
between features and the outcome to predict, and the generation of the actual439
predictive model, are normally ignored.440
In the light of the peculiarities of radiomics, such as the very different441
characteristics of acquired images according to the exploited machine or the442
location of the machine, two lines of evolution of radiomics can be envisaged:443
• General and Portable models. By identifying features that are ro-444
bust with regards to different sources of image noise that can be found445
in images acquired in different centres, it could be possible to generate446
general and portable predictive models, which would allow to exploit447
the availability of numerous –even though sparse– sets of images. On448
the other hand, the focus on portability would lead to under performing449
(when compared to centre-specific) models, with clear negative reper-450
cussion on the quality of the treatment delivered to patients.451
• Centre-specific models. By dropping any requirement related to the452
portability of models, a significant performance boost can be obtained453
by highly optimised centre-specific predictive models. This would allow454
every centre to train a model that is specific for the characteristics of455
the machines, and for the typology of noise which is included in the456
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acquired images. A significant drawback would then be that any change457
in the environment, e.g. a new machine is bought to substitute and458
obsolete one, may dramatically reduce the reliability of the generated459
model. Furthermore, this approach does not allow to investigate, in a460
general sense, the importance and robustness of features.461
In this paper, we introduced a medical agent-based decision support sys-462
tem which is capable of supporting the whole radiomics process3. The agent463
can be given a high level goal, and is then able to reason in order to achieve464
it. Given a set of medical images, the proposed system is able to extract a465
wide range of features, to analyse and select them with regards to the out-466
come to predict, and to generate an optimised predictive models. When data467
from a new patient is provided as input, the proposed agent is able to collect468
features from available medical images and patient’s data, and to return a469
prediction about the clinical outcome of a proposed treatment. Our experi-470
mental analysis demonstrated the ability of the system, and highlighted that471
the proposed architecture is capable of supporting both the lines of research472
mentioned above: predictive models can be optimised for a specific centre,473
and then exchanged in order to analyse the differences. Furthermore, data474
sets can be merged in order to generated general predictive models, or more475
general approaches can be used for the creation of predictive models.476
We see several avenues for future work. We are actively working on four477
aspects.478
1. The exploitation of additional data sets for testing the capability of the479
proposed medical agent-based decision support system to generalise on480
different types of images and contouring.481
2. A graphical user interface, that would create a more comfortable envi-482
ronment for researchers.483
3. The development of additional modules for performing different kind of484
features selection algorithms, and extend the set of techniques that can485
be used for generating the actual predictive model. Specifically, we are486
looking into neural networks [27], SVM [28], and decision trees [29].487
Neural networks will need only a subset of the currently developed488
modules of the proposed decision support agent, but this aspect is489
already supported by the modularity of the system.490
3The agent-based decision support system can be downloaded from https://github.
com/robertogattabs/RadAgent
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4. An approach for extracting information about the spectral components491
(and other measurable aspects) of image noise of images included in the492
considered data set. Such analysis will allow to assess the impact of493
different sort of noise on the predictive capabilities of (some set of)494
considered features, and to better counter-balance it. As a result, it495
would be possible to generate more robust predictive models.496
5. Improving the capabilities of the agent, so that it can explain the ob-497
tained results and motivate the decisions taken.498
6. An architecture to support multi-centric investigation based on the499
distributed learning principles.500
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Appendix A. Detailed List of Features607
Here we provide the list of 92 features exploited in this work. They608
are described in the Image biomarker standardisation initiative Reference609
manual [15]. In order to make it easier, for the interested reader, to identify610
the features in the reference manual, the same id is used in the following list.611
• BASIC612
– 4.1.1 Volume613
– 4.1.3 Surface area614
– 4.1.4 Surface to volume ratio615
23
– 4.1.5 Compactness 1616
– 4.1.6 Compactness 2617
– 4.1.7 Spherical disproportion618
– 4.1.8 Sphericity619
– 4.1.9 Asphericity620
– 4.1.10 Centre of mass shift621
– 4.1.11 Maximum 3D diameter622
– 4.1.12 Major axis length623
– 4.1.13 Minor axis length624
– 4.1.14 Least axis length625
– 4.1.15 Elongation626
– 4.1.16 Flatness627
– 4.3.1 Mean628
– 4.3.2 Variance629
– 4.3.3 Skewness630
– 4.3.4 Kurtosis631
– 4.3.5 Median632
– 4.3.6 Minimum grey level633
– 4.3.7 10th percentile634
– 4.3.8 90th percentile635
– 4.3.9 Maximum grey level636
– 4.3.10 Interquartile range637
– 4.3.11 Range638
– 4.3.12 Mean absolute deviation639
– 4.3.13 Robust mean absolute deviation640
– 4.3.17 Energy641
– 4.3.18 Root mean square642
– 4.4.18 Entropy643
– 4.4.19 Uniformity644
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• Grey level co-occurrence based features – Texture features645
(GLCM)646
– 4.6.1 Joint maximum647
– 4.6.2 Joint average648
– 4.6.3 Joint variance649
– 4.6.4 Joint entropy650
– 4.6.5 Difference average651
– 4.6.6 Difference variance652
– 4.6.7 Difference entropy653
– 4.6.8 Sum average654
– 4.6.9 Sum variance655
– 4.6.10 Sum entropy656
– 4.6.11 Angular second moment657
– 4.6.12 Contrast658
– 4.6.13 Dissimilarity659
– 4.6.14 Inverse difference660
– 4.6.15 Inverse difference normalised661
– 4.6.16 Inverse difference moment662
– 4.6.17 Inverse difference moment normalised663
– 4.6.18 Inverse variance664
– 4.6.19 Correlation665
– 4.6.20 Autocorrelation666
– 4.6.21 Cluster tendency667
– 4.6.22 Cluster shade668
– 4.6.23 Cluster prominence669
– 4.6.24 First measure of information correlation670
– 4.6.25 Second measure of information correlation671
• Grey level run length based features – Texture features (GLRLM)672
25
– 4.7.1 Short runs emphasis673
– 4.7.2 Long runs emphasis674
– 4.7.3 Low grey level run emphasis675
– 4.7.4 High grey level run emphasis676
– 4.7.5 Short run low grey level emphasis677
– 4.7.6 Short run high grey level emphasis678
– 4.7.7 Long run low grey level emphasis679
– 4.7.8 Long run high grey level emphasis680
– 4.7.9 Grey level non-uniformity681
– 4.7.10 Grey level non-uniformity normalised682
– 4.7.11 Run length non-uniformity683
– 4.7.12 Run length non-uniformity normalised684
– 4.7.13 Run percentage685
– 4.7.14 Grey level variance686
– 4.7.15 Run length variance687
– 4.7.16 Run entropy688
• Grey level size zone based features – Texture features (GLDZM)689
– 4.8.1 Small zone emphasis690
– 4.8.2 Large zone emphasis691
– 4.8.3 Low grey level zone emphasis692
– 4.8.4 High grey level zone emphasis693
– 4.8.5 Small zone low grey level emphasis694
– 4.8.6 Small zone high grey level emphasis695
– 4.8.7 Large zone low grey level emphasis696
– 4.8.8 Large zone high grey level emphasis697
– 4.8.9 Grey level non-uniformity698
– 4.8.10 Grey level non-uniformity normalised699
– 4.8.11 Zone size non-uniformity700
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– 4.8.12 Zone size non-uniformity normalised701
– 4.8.13 Zone percentage702
– 4.8.14 Grey level variance703
– 4.8.15 Zone size variance704
– 4.8.16 Zone size entropy705
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